GH
Guardant Health·NASDAQ
--
--(--)
--
--(--)
GH fundamentals
Guardant Health (GH) Revenue Breakdown: Q3 2025 Business & Regional Performance
Guardant Health (GH) reported total revenue of 265.20M USD in Q3 2025, with its core business segment Oncology contributing 69.53%. Regionally, United States remained the largest market, accounting for 94.06% of total revenue. Explore Guardant Health's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Guardant Health (GH) reported total revenue of 265.20M USD in Q3 2025, with its core business segment Oncology contributing 69.53%. Regionally, United States remained the largest market, accounting for 94.06% of total revenue. Explore Guardant Health's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What were the key takeaways from Guardant Health’s earnings call?What is the revenue and EPS growth rate for Guardant Health year over year?What does Guardant Health do and what are its main business segments?What is Guardant Health's latest dividend and current dividend yield?What factors drove the changes in Guardant Health's revenue and profit?What were the key takeaways from Guardant Health's earnings call?What guidance did Guardant Health's management provide for the next earnings period?What is the market's earnings forecast for Guardant Health next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
